Glaxosmithkline | Spese Operative

Operating Expenses Cambiamento Data
AstraZeneca USD 9.54B 578M 2023-09
Aurora Cannabis CAD 141.63M 8.62M 2023-03
Pacira USD 148.08M 1.87M 2023-12
Perrigo USD 1.06B 74.6M 2023-09
Prestige Brands USD 195.91M 2.16M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12
Takeda JPY 1.09T 202.38B 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09



Glaxosmithkline Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.